M
Myriad Genetics
Biotech & Life Sciences · Salt Lake City, United States · Founded 1991 · IPO 1995 Thoroughbred
Investors
1 investor on Myriad Genetics's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Myriad Genetics has talent and traffic
(16 of 2,856 staff)
team presence
across markets
Capital deployed
Myriad Genetics's 10 investments and acquisitions.
Every disclosed deal where Myriad Genetics appeared as a backer or acquirer, 2009–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
10 deals across Myriad Genetics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Myriad Genetics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Myriad Genetics
An AI-synthesized read of the highest-engagement posts about Myriad Genetics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Myriad Genetics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.